Prasad Kopparapu

591 total citations
11 papers, 330 citations indexed

About

Prasad Kopparapu is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Prasad Kopparapu has authored 11 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Prasad Kopparapu's work include Retinoids in leukemia and cellular processes (3 papers), Nuclear Receptors and Signaling (3 papers) and Lung Cancer Research Studies (3 papers). Prasad Kopparapu is often cited by papers focused on Retinoids in leukemia and cellular processes (3 papers), Nuclear Receptors and Signaling (3 papers) and Lung Cancer Research Studies (3 papers). Prasad Kopparapu collaborates with scholars based in United States and Switzerland. Prasad Kopparapu's co-authors include Siva K. Kolluri, Edmond F. O’Donnell, Nancy I. Kerkvliet, Daniel C. Koch, Hyo Sang Jang, Robert L. Tanguay, William H. Bisson, David Farrer, Lijoy K. Mathew and Sumit Punj and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Prasad Kopparapu

10 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prasad Kopparapu United States 8 141 93 83 66 56 11 330
Brandie N. Radde United States 12 194 1.4× 78 0.8× 47 0.6× 79 1.2× 39 0.7× 12 395
Manabu Matsunawa Japan 9 135 1.0× 67 0.7× 31 0.4× 19 0.3× 39 0.7× 22 401
Naveen Kumar Khare India 12 208 1.5× 72 0.8× 25 0.3× 92 1.4× 50 0.9× 24 381
Glennwood E. Trivers United States 7 135 1.0× 53 0.6× 83 1.0× 186 2.8× 56 1.0× 9 372
Oscar Betancourt United States 5 195 1.4× 92 1.0× 25 0.3× 42 0.6× 56 1.0× 19 402
Sangyun Shin South Korea 9 174 1.2× 69 0.7× 14 0.2× 71 1.1× 31 0.6× 20 317
J. Peter McPherson Canada 11 341 2.4× 186 2.0× 23 0.3× 62 0.9× 66 1.2× 15 505
Anna Ferreri Italy 13 315 2.2× 97 1.0× 24 0.3× 95 1.4× 32 0.6× 36 462
Julie Rageul United States 11 210 1.5× 74 0.8× 20 0.2× 78 1.2× 19 0.3× 17 299
Phillip M. Shelton United States 6 294 2.1× 91 1.0× 14 0.2× 70 1.1× 40 0.7× 8 411

Countries citing papers authored by Prasad Kopparapu

Since Specialization
Citations

This map shows the geographic impact of Prasad Kopparapu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasad Kopparapu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasad Kopparapu more than expected).

Fields of papers citing papers by Prasad Kopparapu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasad Kopparapu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasad Kopparapu. The network helps show where Prasad Kopparapu may publish in the future.

Co-authorship network of co-authors of Prasad Kopparapu

This figure shows the co-authorship network connecting the top 25 collaborators of Prasad Kopparapu. A scholar is included among the top collaborators of Prasad Kopparapu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasad Kopparapu. Prasad Kopparapu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kopparapu, Prasad, Christiane V. Löhr, Hyo Sang Jang, et al.. (2024). Identification and Characterization of a Small Molecule Bcl-2 Functional Converter. Cancer Research Communications. 4(3). 634–644. 2 indexed citations
2.
Kopparapu, Prasad, et al.. (2024). Small Molecule Functional Converter of B-Cell Lymphoma-2 (Bcl-2) Suppresses Breast Cancer Lung Metastasis. ACS Pharmacology & Translational Science. 7(5). 1302–1309.
3.
Finlay, Darren, Prasad Kopparapu, Robert L. Tanguay, et al.. (2022). 11‐Cl‐BBQ , a select modulator of AhR ‐regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27 Kip1 . FEBS Journal. 290(8). 2064–2084. 7 indexed citations
4.
Kopparapu, Prasad, Edward Chin Man Lo, Yingjun Yan, et al.. (2022). Abstract 3375: Molecular subtyping of circulating tumor cells in patients with small cell lung cancer. Cancer Research. 82(12_Supplement). 3375–3375. 1 indexed citations
5.
Groves, Sarah M., Jia Li, Paula I. González-Ericsson, et al.. (2021). Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC. Journal of Thoracic Oncology. 16(7). 1211–1223. 21 indexed citations
6.
Iams, Wade T., Prasad Kopparapu, Yingjun Yan, et al.. (2020). Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease. JTO Clinical and Research Reports. 1(2). 100024–100024. 16 indexed citations
7.
Kopparapu, Prasad, Edmond F. O’Donnell, Hyo Sang Jang, et al.. (2018). Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells. Oncotarget. 9(40). 26072–26085. 36 indexed citations
8.
Koch, Daniel C., Hyo Sang Jang, Edmond F. O’Donnell, et al.. (2015). Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1. Oncogene. 34(50). 6092–6104. 41 indexed citations
9.
Punj, Sumit, Prasad Kopparapu, Hyo Sang Jang, et al.. (2014). Benzimidazoisoquinolines: A New Class of Rapidly Metabolized Aryl Hydrocarbon Receptor (AhR) Ligands that Induce AhR-Dependent Tregs and Prevent Murine Graft-Versus-Host Disease. PLoS ONE. 9(2). e88726–e88726. 39 indexed citations
10.
O’Donnell, Edmond F., Prasad Kopparapu, Daniel C. Koch, et al.. (2012). The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells. PLoS ONE. 7(7). e40926–e40926. 66 indexed citations
11.
O’Donnell, Edmond F., Katerine S. Saili, Daniel C. Koch, et al.. (2010). The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor. PLoS ONE. 5(10). e13128–e13128. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026